|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/4709 | |
| A61K 31/505 | |||
| A61K 31/506 | |||
| A61K 31/519 | |||
| A61P 27/02 |
| (11) | Patento numeris | 2632458 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 11779606.0 |
| Europos patento paraiškos padavimo data | 2011-10-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2013-09-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2015-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/EP2011/068682 |
| Data | 2011-10-25 |
| (87) | Numeris | WO 2012/055884 |
| Data | 2012-05-03 |
| (30) | Numeris | Data | Šalis |
| 407218 P | 2010-10-27 | US |
| (72) |
BRIGELL, Mitchell, US
END, Peter, CH
HOSAGRAHARA, Vinayak, IN
JAFFEE, Bruce, US
MEREDITH, Erik, US
NEWTON, Ronald, US
POOR, Stephen, US
QIU, Yubin, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (54) | DOSING REGIMES FOR THE TREATMENT OF OCULAR VASCULAR DISEASE |
| DOSING REGIMES FOR THE TREATMENT OF OCULAR VASCULAR DISEASE |